Tag
oncology
- Allarity Therapeutics settles US$4.9M liability for US$1M
- Merck raises sales outlook after US$18.1B third quarter
- Incyte raises sales outlook as quarterly revenue reaches US$1.56B
- AbbVie receives two FDA breakthrough designations for Temab‑A
- Genmab A/S reports 51% lower progression or death risk in Phase 3 lymphoma trial
- Eli Lilly and Company wins first-line Jaypirca approval for CLL/SLL
- Summit Therapeutics plans Phase III Datroway breast cancer trial
- Summit Therapeutics agrees to US$2B AstraZeneca equity investment
- Merck closes SciBrunch KRAS licence worth up to US$2.13B
- bioAffinity Technologies jumps 63% on Hong Kong lung cancer screening patent
- BioNTech's lung cancer drug outperforms chemo in clinical study
- Arm CEO's AI cancer cure claims come amid pushback over similar ideas
- Psychedelic compound psilocybin shows promise for preventing chemo nerve damage
- Radiation-free scan lights up elusive lung cancer in mice
- Europe authorises Vara AI to clear low‑risk mammograms without human read
- bioAffinity jumps 45% from lung cancer phlegm test expansion
- Revolution's newly approved drug doubles pancreatic cancer survival time
- Propanc Biopharma skyrockets from pancreatic cancer drug breakthrough
- Young Muay Thai fighter's lung cancer death raises screening eligibility concerns
- Craif raises US$33M to get its urine cancer test into American clinics
- Moderna ascends more than 175% from cancer vaccine breakthrough
- Research shines light on efficacy of 'Inflammacheck' lung cancer breath test
- Freenome gets FDA breakthrough designation for 'SimpleScreen' lung cancer blood test
- Median Technologies partners with Canon Medical to achieve lung cancer screening goals
- Stand Up To Cancer charity funds non‑invasive lung cancer screening projects
- Replimune tanks on FDA concerns about its skin cancer therapy
- Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test
- AI‑powered light scan could speed up targeted lung cancer treatments
- Moroccan medtech leader T2S gets green light for Casablanca IPO
- Pigeons help prevent radiologists from missing malignancies on CT scans
- Tumour freezing specialist IceCure Medical skyrockets from latest successes
- Liquid chromatography-mass spectrometry proves its worth in lung cancer screening
- BioMark expands lung cancer screening portfolio with patented urine test
- AI‑powered blood test promises lung cancer detection 5 years in advance
- International research surge highlights asbestos health crisis
- Novartis advances actinium-based cancer drug after promising trial data
- Cuban lung cancer vaccine 'VAXIRA' pulls spotlight with innovation award
- Cambridge researchers develop urine test that could detect lung cancer years earlier
- China's Westlake University develops palm-sized lung cancer blood test
- Guardant gets FDA nod for next‑gen cancer mutation blood test
- Susan Wojcicki Foundation unites tech and healthcare leaders against lung cancer
- University of Manitoba researchers develop dual-mode breast cancer imaging system
- CNS Pharma sees 250% spike from oversubscribed private placement
- Cancer protein found to self-activate, reshaping understanding of tumor growth
- New blood test approach could detect multiple cancers earlier, researchers say
- Genprex partners with University of Texas for lung cancer biomarker research
- Researchers probe diet link as lung cancer rises in young non‑smokers
- Philips secures FDA approval for its AI‑powered CT tech
- Merck provides grant funding to boost American lung cancer screening rates
- Cancer remains Canada’s top killer as 2026 cases exceed 254,000